Authors: Vasey, PA Atkinson, R Coleman, R Crawford, M Cruickshank, M Eggleton, P Fleming, D Graham, J Parkin, D Paul, J Reed, NS Kaye, SB

Citation: Pa. Vasey et al., Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer, BR J CANC, 84(2), 2001, pp. 170-178

Authors: Massel, D Cruickshank, M

Citation: D. Massel et M. Cruickshank, Greater expectations in a cancer trial: Absolute more than relative survival increases, community more than academic clinicians, CANCER INV, 18(8), 2000, pp. 798-803

Authors: Savage, KJ Wells, PS Schulz, V Goudie, D Morrow, B Cruickshank, M Kovacs, MJ

Citation: Kj. Savage et al., Outpatient use of low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity, THROMB HAEM, 82(3), 1999, pp. 1008-1010

Authors: McLaughiin, K Cruickshank, M Hollomby, D Jevnikar, A Muirhead, N

Citation: K. Mclaughiin et al., Idiopathic thrombocytopenia after cytomegalovirus infection in a renal transplant recipient, AM J KIDNEY, 33(6), 1999, pp. E61-E63

Authors: Kovacs, MJ Cruickshank, M Wells, PS Kim, H Chin-Yee, I Morrow, B Boyle, E Kovacs, J

Citation: Mj. Kovacs et al., Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease, HAEMOSTASIS, 28(2), 1998, pp. 62-69